CC
CRBU icon

Centiva Capital’s Caribou Biosciences CRBU Stock Holding History

Centiva Capital’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,657
Closed -$45.3K – 1762
2023
Q2 		$45.3K Buy
+10,657
New +$47.9K ﹤0.01% 1511

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Centiva Capital's CRBU Position: Q3 2023 in Review

Centiva Capital sold out of Caribou Biosciences (CRBU) in Q3 2023, closing a stake of 10,657 shares — an estimated $45.3K sold.

Centiva Capital first reported a position in CRBU in Q2 2023 and held it in 1 quarter. The position peaked at $45.3K in Q2 2023. 126 funds tracked by Wall St. Rank hold CRBU as of Q3 2023.

  • Centiva Capital reported no remaining Caribou Biosciences position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 10,657 Caribou Biosciences shares in Q3 2023, an estimated $45.3K.
  • Centiva Capital first reported a position in Caribou Biosciences in Q2 2023 and held it in 1 quarter.
  • Centiva Capital's Caribou Biosciences position peaked at $45.3K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.